ExecuPharm Functional Service Solutions

August 22, 2017

Today, functional service outsourcing represents 22% of the total clinical development outsourcing market, making it clear that biopharmaceutical companies need flexible options for outsourcing models.*

PAREXEL recently acquired ExecuPharm, a leading global functional service provider, creating one of the largest global FSS/FSP teams. Our expanded solution allows biopharmaceutical companies to fulfill all of their clinical development outsourcing needs through a single integrated company, resulting in expanded global presence, increased therapeutic expertise, broad product development knowledge, and high quality service.

Previous Flipbook
Bioanalytics and Biomarker Services
Bioanalytics and Biomarker Services

Meet your goals sooner with the expertise and state-of-the-art technology you need.

Next Flipbook
Accelerating Access to Study Investigators, Patients and Efficacy Data
Accelerating Access to Study Investigators, Patients and Efficacy Data

Learn how you can drive your study to success with intelligent planning, focused execution, state-of-the-ar...